Form 4 for CRDF Cardiff Oncology, Inc.
Accepted 2024-12-18 00:00:00 ET · period of report 2024-12-16 · accession 0000950170-24-137938 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-12-18 | 2024-12-16+ | CRDF | Levine James E. | CFO | P - Purchase | $4.76 | +7,716 | 67.7K | +13% | +$36.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-16 | P | A | 2,564 | $3.83 | 62,564 | I By Wife | — | — | |
| 2 | Common | Common Stock | 2024-12-17 | P | A | 2,752 | $5.42 | 65,316 | I By Wife | — | — | |
| 3 | Common | Common Stock | 2024-12-18 | P | A | 2,400 | $5.00 | 67,716 | I By Wife | — | — |